| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Roche Holding AG (VX: ROG)
ROG Technical Analysis
5
| As on 20th Jan 2022 ROG SHARE Price closed @ 365.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 320.82 & Strong Buy for SHORT-TERM with Stoploss of 307.56 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ROGSHARE Price
| Open | 365.80 | Change | Price | % |
| High | 366.20 | 1 Day | -0.60 | -0.16 |
| Low | 362.70 | 1 Week | -10.45 | -2.78 |
| Close | 365.10 | 1 Month | -3.15 | -0.86 |
| Volume | 950522 | 1 Year | 47.20 | 14.85 |
| 52 Week High 383.60 | 52 Week Low 293.90 | ||||
VX Switzerland Most Active Stocks
| CSGN | 9.13 | 0.77% |
| CSGN | 9.13 | 0.77% |
| UBSG | 17.68 | 0.11% |
| UBSG | 17.68 | 0.11% |
| NOVN | 81.39 | -0.09% |
| NOVN | 81.39 | -0.09% |
| ABBN | 34.39 | 1.15% |
| ABBN | 34.39 | 1.15% |
| ARYN | 1.11 | -1.77% |
| ARYN | 1.11 | -1.77% |
VX Switzerland Top Gainers Stocks
VX Switzerland Top Losers Stocks
| ROG Daily Charts |
ROG Intraday Charts |
Whats New @ Bazaartrend |
ROG Free Analysis |
|
|
ROG Important Levels Intraday
| RESISTANCE | 371.84 |
| RESISTANCE | 369.68 |
| RESISTANCE | 368.34 |
| RESISTANCE | 367.01 |
| SUPPORT | 363.19 |
| SUPPORT | 361.86 |
| SUPPORT | 360.52 |
| SUPPORT | 358.36 |
ROG Forecast April 2024
| 4th UP Forecast | 435.44 |
| 3rd UP Forecast | 412.88 |
| 2nd UP Forecast | 398.94 |
| 1st UP Forecast | 384.99 |
| 1st DOWN Forecast | 345.21 |
| 2nd DOWN Forecast | 331.26 |
| 3rd DOWN Forecast | 317.32 |
| 4th DOWN Forecast | 294.76 |
ROG Weekly Forecast
| 4th UP Forecast | 393.23 |
| 3rd UP Forecast | 384.21 |
| 2nd UP Forecast | 378.63 |
| 1st UP Forecast | 373.06 |
| 1st DOWN Forecast | 357.14 |
| 2nd DOWN Forecast | 351.57 |
| 3rd DOWN Forecast | 345.99 |
| 4th DOWN Forecast | 336.97 |
ROG Forecast2024
| 4th UP Forecast | 545.56 |
| 3rd UP Forecast | 487.69 |
| 2nd UP Forecast | 451.91 |
| 1st UP Forecast | 416.14 |
| 1st DOWN Forecast | 314.06 |
| 2nd DOWN Forecast | 278.29 |
| 3rd DOWN Forecast | 242.51 |
| 4th DOWN Forecast | 184.64 |
Roche Holding AG ( VX Switzerland Symbol : ROG )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
ROG Business Profile
Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, liver, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases. The company provides diagnostic solutions, such as blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring; diabetes therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogeneous immuno assays; immunology; infectious diseases; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control service; real-time PCR diagnostic systems; serum work area; urinalysis; and workflow solutions. Roche Holding AG has a strategic alliance with Wisconsin Diagnostic Laboratories; and a collaboration agreement with Five Prime Therapeutics, Inc. The company was founded in 1896 and is headquartered in Basel, Switzerland. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service